For research use only. Not for therapeutic Use.
Asenapine maleate(Cat No.:I000516)is an atypical antipsychotic medication primarily used to treat schizophrenia and bipolar disorder. It works by affecting neurotransmitters in the brain, particularly dopamine and serotonin, helping to balance their activity. This can reduce symptoms such as delusions, hallucinations, mood swings, and aggression. Asenapine is administered either sublingually or as an injection, and it has the advantage of being less likely to cause certain side effects, such as weight gain, compared to other antipsychotics. Common side effects include dizziness, drowsiness, and a dry mouth. It is prescribed when other treatments are ineffective.
Catalog Number | I000516 |
CAS Number | 85650-56-2 |
Synonyms | Org 5222; Org5222; Org-5222; HSDB 8061; HSDB-8061; HSDB8061; Asenapine; Asenapine maleate; trade names Saphris and Sycrest.;(3aS,12bS)-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole maleate |
Molecular Formula | C17H16ClNO.C4H4O4 |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | Soluble in DMSO, not in water |
Storage | 3 years -20C powder |
Related CAS | 65576-45-6(free base) |
Overview of Clinical Research | Asenapine maleate is an alpha adrenergic receptor antagonist and a dopamine receptor antagonist developed by AbbVie. |
IUPAC Name | (Z)-but-2-enedioic acid;(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene |
InChI | InChI=1S/C17H16ClNO.C4H4O4/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19;5-3(6)1-2-4(7)8/h2-8,14-15H,9-10H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,15-;/m1./s1 |
InChIKey | GMDCDXMAFMEDAG-CHHFXETESA-N |
SMILES | CN1C[C@H]2[C@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24.C(=C\C(=O)O)\C(=O)O |